Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia
|更新时间:2024-01-04
|
Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 12, Pages: 242-245(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
FU Man-hua, XU Min, JI Qing-ming. Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(12): 242-245.
DOI:
FU Man-hua, XU Min, JI Qing-ming. Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(12): 242-245.DOI:
Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia
Objective: To carry out a morphological study on the protective effect of Tamoxifen combined with Pisuxiao in rats of mammary gland hyperplasia. Method: Rat were randomized into 7 groups:nomal
model
Tamoxifen(Tam) with Pisuxiao(PSX
3.0
1.5
0.75 g·kg-1)and Tamoxifen (1.67 mg·kg-1)
Pisuxiao (2.5 g·kg-1)
and ig for 45 days.Rat models of of mammary glands hyperplasia were established by intramuscular injection of estradiol benzoate (E2)and progesterone(P). Pathologic histopathology of the breast tissue was check up under the microscope.The estradiol and progesterone contents were determined.Estrogen receptor (ER) and progesterone receptor (PR) were evaluated by immunohistochemical technique. Result: In compare with model groups
the estradiol level of Tam with PSX group was evidently lower than that in the model group
Tamoxifen with Pisuxiao could inhibit the ductal and lobular hyperplasia and induce hyperplasia(P<0.01 or P<0.05)
reduce the content of E2 and P in serum (P<0.01).At the sametime ER and PR expressionwere obviously inhibited(P<0.01 or P<0.05). Conclusion: Tamoxifen combined with Pisuxiao is protective in rats withexperimental mammary glands hyperplasia.